Moberg Pharma AB

ISIN SE0003495431Filings at the FI

At a glance

Most recent filing on December 12, 2019 — a sale by Mark Beveridge on Dec 9, 2019.

We hold 1 visible filing, going back to December 9, 2019.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

All 1 shown

  • Mark Beveridge Chief financial officer
    45,305 SEKOpen-market sale
    TradedDec 9, 2019FiledDec 12, 2019